inflammation · Mechanism Report
Can FADS1 and FADS2 variants influence inflammatory lipid mediator substrates?
FADS1 and FADS2 variants can alter long-chain fatty-acid synthesis and shift the substrates available for inflammatory and inflammation-resolving mediators.
This is what AI claimed
FADS1 and FADS2 variants can alter long-chain polyunsaturated fatty-acid synthesis and thereby influence the substrate balance for inflammatory and inflammation-resolving lipid mediators.
Executive summary
These variants are associated with differences in fatty-acid conversion and estimated desaturase activity. Changes in long-chain fatty-acid availability may affect mediator precursors, but do not predict an individual's inflammatory state or clinical outcomes.
Verified conclusion
At age 52, this claim is biologically well supported: common variation in the FADS1/FADS2 region can change endogenous long-chain polyunsaturated fatty-acid (PUFA) handling, which in turn changes the lipid substrates available to inflammatory and resolution-related mediator pathways. This describes metabolic potential, not a proven prediction of inflammation or clinical outcomes for an individual.
Genetic and metabolic evidence
- FADS1 rs174537 G associates with higher arachidonic acid (AA), lower dihomo-γ-linolenic acid (DGLA), and a higher AA/DGLA ratio, a proxy for Δ5-desaturase activity. In one European-descent founder cohort, it explained 24% of variation in the reported n-6 FADS1 activity ratio.
- For FADS2, rs1535 G was associated with lower estimated activity: AA/linoleic-acid ratios declined from 2.01 (AA) to 1.76 (AG) and 1.62 (GG) in a post-myocardial-infarction cohort.
- Controlled feeding studies provide functional corroboration: EPA rose with high α-linolenic-acid intake only in rs174550 TT participants in one randomized trial, and AA responses to high linoleic-acid intake differed by genotype.
Mediator-substrate implications
- AA is a substrate for inflammatory eicosanoid pathways, whereas EPA and DHA supply omega-3-derived oxylipins and precursors of specialized pro-resolving mediators.
- In a 12-month randomized trial of adults with low fish intake, higher EPA+DHA intake dose-dependently increased EPA/DHA-derived oxylipins, including 17-HDHA and 18-HEPE, precursors of resolution mediators.
- FADS-locus variants also track with lower long-chain-PUFA-containing lipid species and relatively higher precursor species, consistent with a shifted substrate pool.
Mechanistic interpretation
- Genotype-associated product:precursor ratios indicate altered estimated desaturase activity, although these ratios are surrogates rather than direct enzyme assays.
- Changes in conversion of dietary linoleic acid or α-linolenic acid to downstream PUFAs offer a plausible route by which genotype modifies mediator precursors.
Bottom line
- FADS1/FADS2 variants can alter long-chain PUFA synthesis and plausibly shift substrates for both inflammatory and inflammation-resolving lipid mediators. They do not, by themselves, establish an individual’s inflammatory state, mature specialized pro-resolving mediator levels, or a need for genotype-guided supplementation.
References
- The FADS1 rs174550 Genotype Modifies the n‐3 and n‐6 PUFA ... — pmc.ncbi.nlm.nih.gov
- The impact of fatty acid desaturase genotype on ... — cambridge.org
- FADS genetic variants and ω-6 polyunsaturated fatty acid ... — pmc.ncbi.nlm.nih.gov
- Genetic variation in polyunsaturated fatty acid metabolism and its ... — pmc.ncbi.nlm.nih.gov
- journals.plos.org · plosone · articleGenetic profiling of fatty acid desaturase polymorphisms ... — journals.plos.org
- Polyunsaturated fatty acid levels in blood during pregnancy, at birth and at 7 years: their associations with two common FADS2 polymorphisms — pmc.ncbi.nlm.nih.gov
- Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans — ora.ox.ac.uk
- FADS genetic and metabolomic analyses identify the ∆5 desaturase (FADS1) step as a critical control point in the formation of biologically important lipids - Scientific Reports — link.springer.com
- Genetic variation at the FADS1-FADS2 gene locus ... — pubmed.ncbi.nlm.nih.gov
- Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids ... — pmc.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough